Erectile dysfunction decisions — 2025

The Board of Veterans' Appeals remands the Veteran's claims for increased ratings for various service-connected conditions due to an error by the Agency of Original Jurisdiction in failing to provide notice of the Veteran's right to a pre-decisional hearing.

The Board granted the application to readjudicate the claim for service connection for erectile dysfunction (ED) and denied it for gastroesophageal reflux disease (GERD). The ED claim was remanded for further action.

The Board denied earlier effective dates for the awards of service connection for prostate cancer, erectile dysfunction, and a scar, as well as special monthly compensation based on loss of use of creative organ.

The Board granted service connection for erectile dysfunction as secondary to the Veteran's service-connected posttraumatic stress disorder (PTSD) and migraine headaches.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded certain claims for further development.

The appeal was dismissed due to the lack of a current disability for athlete's foot, left foot pain, right ankle pain, and vision disorder. The claims for tinnitus and erectile dysfunction were also dismissed as they were fully granted in a subsequent rating decision.

The appeal for service connection for sleep apnea and erectile dysfunction was withdrawn by the Veteran's representative, and the Board has no jurisdiction to review the appeal.

The Board granted an earlier effective date of October 3, 2014, for service connection for erectile dysfunction and special monthly compensation (SMC) for loss of use of a creative organ.

The Board denied service connection for headaches, a thoracolumbar spine disorder, erectile dysfunction, and a left knee disorder. The Veteran was granted an effective date of September 6, 2018, but not earlier, for the assignment of a rating of 100 percent for his service-connected acquired psychiatric disability.

The Board remands the claim for service connection of erectile dysfunction (ED) secondary to service-connected disabilities due to an inadequate VA examination.

The Board granted service connection for erectile dysfunction as it is proximately due to the Veteran's service-connected disabilities, including hypertension, PTSD, and alcohol use disorder.

The Board granted an initial rating of 80 percent for sciatic radiculopathy of the left lower extremity and special monthly compensation (SMC) at the 'k' rate, both effective October 22, 2019.

The Board granted an effective date of March 23, 2021, for the grant of service connection for ED and SMC based on loss of use of a creative organ, as well as a 70 percent disability rating for PTSD. The assignment of a 50 percent disability rating for migraine headaches was denied.

The Board granted service connection for major depressive disorder and denied service connection for anemia, high cholesterol, muscle aches, benign prostatic hyperplasia, erectile dysfunction, frostbite residuals, gonorrhea residuals, and hypertension.

The Board remands the claims for an earlier effective date and a compensable evaluation for service-connected erectile dysfunction due to a need for additional information regarding the November 2023 examination.

The Board denied increased ratings for the Veteran's left wrist degenerative arthritis, migraines, bilateral hearing loss, eye disability, and sciatica of the right lower extremity. However, it granted a 40 percent rating for back disability, service connection for erectile dysfunction secondary to the back disability, and special monthly compensation based on loss of use of a creative organ.

The Board remands the claims for service connection for diabetes mellitus type II, erectile dysfunction, and bilateral peripheral neuropathy due to a need for further development of evidence related to herbicide exposure.

The Board granted service connection for erectile dysfunction, obstructive sleep apnea, and hypertension, all as secondary to the Veteran's service-connected posttraumatic stress disorder.

The Board granted earlier effective dates of March 14, 2017, for service-connected erectile dysfunction, bladder cancer with acquired urinary incontinence and frequency of micturition, and special monthly compensation (SMC) based on loss of use of a creative organ.

The Board granted readjudication of the claims for service connection for erectile dysfunction, heart condition, hypertension, mental health condition, and sleep apnea based on new and relevant evidence. The claims for flat feet (pes planus) with plantar fasciitis were remanded for additional examination.